2. • Chronic Obstructive Pulmonary Disease
• A progressive disease that affects the lungs,
making it difficult to breathe
3. Other names for COPD
• Chronic Obstructive Lung Disease (COLD)
• Chronic Lower Respiratory Disease (CLRD)
4. COPD
• Chronic obstructive pulmonary disease
(COPD) is a lung ailment that is characterized
by a persistent blockage of airflow from the
lungs.
• It is an under-diagnosed, life-threatening lung
disease that interferes with normal breathing
and is not fully reversible.
5. COPD: an umbrella term
• Umbrella term used to describe
progressive lung diseases which
include:
• Emphysema
• Chronic bronchitis
• Asthma
• Severe bronchiectasis
• Small airway disease
6. EMPHYSEMA
Abnormal permanent enlargement of the air
spaces distal to the terminal
bronchioles,accompanied by destruction of
their walls without significant fibrosis
13. CENTRIACINAR
• Most common ; >20%
• Central or proximal
parts of the acini ,
respiratory bronchioles
are affected while distal
alveoli are spared
• Severe type affects the
distal alveoli as well
• Seen in cigrette smokers
15. PANACINAR
• Lower lung zone
• Acini are uniformly
enlarged , from the level
of the respiratory
bronchiole to the
terminal blind alveoli
• Usually seen in α1-
antitrypsin deficiency
16.
17. DISTAL ACINAR
• The proximal portion of the acinus is normal but
the distal part is primarily involved
• Unknown cause spontaneous pneumothorax
in young adults
• Charecteristic finding : multiple , contigious ,
enlarged air spaces ranging in diameter from
<0.5mm to >2.0cm
• Sometimes forming cystic structures that , with
progressive enlargement , are referred to as
bullae
18. IRREGULAR EMPHYSEMA
• Acinus is irregularly involved , is almost
invariably associated with scarring
• Clinically asymtomatic
19.
20. MACROSCOPIC FEATURES
• Voluminous ,pale with
little blood
• Edges of lungs are
rounded &show
dilatation of air spaces
• Subpleural bullae and
blebs bulging outwards
23. MICROSCOPIC FEATURES
• Destruction of alveolar wall with out fibrosis , leading to
enlarged air spaces
• The number of alveolar capillaries is diminished
• Terminal and respiratory bronchioles may be deformed
because of the loss of septa that help tether these structures
in the parenchyma
24.
25.
26. CLINICAL FEATURES
• Long history of slowly increasing severe
exertional dyspnoea
• Obvius use of accessory muscles of
respiration
• Chest is barrel-shaped &
hyperresonant.
• Cough occours late after dyspnoea
starts & is associated with scanty
mucoid sputum.
• Recurrent respiratory infections are
not frequent
27. Complication of emphysema
• Pulmonary failure with respiratory acidosis
• Hypoxia
• Coma
• Right-sided heart failure (cor pulmonale)
28. CHRONIC BRONCHITIS
• It is defined clinically as a persistant cough
with expectoration most days for at least
three months of the year for two or more
consecutive years.
• The cough is caused by over secretion of
mucus
39. BRONCHIAL ASTHMA
• Asthma is a chronic inflammatory disorder of
the airways that causes recurrent episodes of
wheezing ,breathlessness ,chest tightness ,&
cough particularly at night and /or early in the
morning.
41. • Atopic
Evidence of allergen sensitization ,often in a patient
with a history of allergic rhinitis,eczema
• Nonatopic
• Bronchospasm can be triggered by
1.Respiratory infections
2.Environmental exposure to irritants
3.Cold air
4.Stress
5.Exercise
42.
43. Atopic Asthma
• Most common
• Usually begin in childhood , classic example of type 1
IgE-mediated HS
• A positive family history ;Dusts ,pollen ,animal
dander , and foods
• Infections can also be a trigger
• A skin test ; immediate wheal- and flare reaction
• Diagnosis based on serum radioallergenosorbent
tests (RASTs) that identify the presence of IgE
specific for a panel of allergens.
44. Non-Atopic Asthma
• No evidence of allergen sensitization
• Skin test ;usually negative
• A positive family history of asthma is less common
• Respiratory infections due to viruses and inhaled air
pollutants are common triggers
• It is thought that virus- inducedinflammation of the
respiratory mucosa lowers the threshold of the subepithelial
vagal receptors to irritants
• Humoral and cellular mediators of airway obstruction are
common to atopic and nonatopic variants of asthma
45. Drug induced asthma
• Aspirin
• Patients with aspirin sensitivity present with
recurrent rhinitis & nasal polyps ,urticaria ,and
bronchospasm
• Mechanism remains unknown
• It is presumed that aspirin inhibit the cyclooxygnase-
1 pathway of arachidonic acid metabolism without
affecting the lipoxygenase route
• Thereby shifting the balance of production towards
leukotrienes that cause bronchial spasm
46. Occupational Asthma
• Stimulated by fumes (epoxy resins plastics)
,organic and chemical dusts (wood , cotton ,
platinum) ,gases (toluene) ,and other
chemicals
• Asthma attacks usually develop after repeated
exposure to the inciting antigen
47. MORPHOLOGY
Gross
• lungs are overdistended because of
overinflation
• Small areas of atelectasis
• Occlusion of bronchi and bronchioles by thick ,
tenacious mucous plugs
48. MICROSCOPY
• Mucous plugs contain whorls of shed epithelium (curschmann
spirals)
• Numerous eosinophils and Charcot-leyden crystals (collection
of crystalloids made up of eosinophil proteins)
• Airway remodelling include
• Thickening of airway wall
• Sub-basement membrane fibrosis
• Increased vascularity in sub mucosa
• An increase in size of the sub mucosal glands and globlet cell
metaplasia of the airway epithelium
• Hypertrophy and/or hyperplasia of the bronchial muscle
52. BRONCHIECTASIS
• Bronchiectasis is the permanent dilation of
bronchi and bronchioles caused by
destruction of the muscle and the supporting
elastic tissue , resulting from or associated
with chronic necrotizing infections
53. • Secondary to persisting infection or
obstruction caused by a variety of conditions
• Charecteristic symptom:cough
&expectoration of copious amounts of foul
purulent sputum
• Diagnosis: patient history +radiographic
bronchial dilatation
54. Etiology
• Bronchial obstruction
• Congenital or heriditary conditions :-
o In cystic fibrosis
o In immunodeficiency state
o Kartagener syndrome
• Necrotizing or suppurative pneumonia
55. pathogenesis
• Two processes are crucial
Obstruction
Chronic persistant infection
• Either of these may come first
• Usually affects the lower lobes bilaterally
56. Morphology
GROSS
• Most severe involvement is more distal
bronchi and bronchioles
• Airways are dilated
• Bronchioles can be seen on the pleural
surfaces
57.
58. Microscopy
• Vary with the activity and chronicity of the
disease
• In the usual case, a mixed flora can be
cultured from the involved bronchi
• Hyperplasia of epithilium metaplasia of
epithelium in to squamous cell
59. • Full blown active case:-
• An intense acute and chronic inflammatory
exudate with in the walls of the bronchi and
bronchioles
• Desqumation of lining epithelium cause
extensive areas of ulceration
60. • Healing-lining epithelium may regenerate
completely
• Healing in chronic case- fibrosis of the
bronchial and bronchiolar wall and
peribronchiolar fibrosis
• In some instances , necrosis destroys the
bronchial or bronchiolar walls
formation of an abcess cavity within which a
fungus ball may develop
61. Clinical features
• Severe , persistant cough with expectoration
of mucopurilent , sometimes fetid sputum
• Sputum: flecks of blood , frank hemoptysis
• Symptoms are episodic , precipitated by upper
respiratory tract infections or new pathogenic
agents
• Clubbing
• Hypoxemia , hypercapnia , pulmonary
hypertension and cor pulmonale (rare)
Chronic Obstructive Pulmonary Disease is a life-threatening lung disease. It is considered a progressive disease meaning that the disease grows more severe over time.
Chronic Obstructive Pulmonary Disease refers to a problem with breathing air out from your lungs. Until recently, most people who had COPD were grouped together and considered to have one disease. We now know that several different diseases cause this difficulty in releasing air from the lungs. Asthmatic bronchitis, chronic bronchitis, and emphysema are three of the major diseases that are grouped together as COPD. Thus, COPD is not just one specific disease but a group of diseases which all cause difficulty breathing.